All Posts
May 20, 2026
CyberKnife – The "Precision Drone" in Radiation Therapy
CyberKnife is a robotic radiosurgery system that tracks tumors in real time, striking targets at millimeter precision while protecting surrounding healthy tissue.
Read more →
May 19, 2026
What Is the Time-lapse Embryo Culture System and Its Advantages?
Time-lapse technology lets embryologists observe an embryo's entire development in real time inside the incubator, improving pregnancy rates and reducing early miscarriage in IVF.
Read more →
May 18, 2026
Relapsed/Refractory DLBCL: A Breakthrough in Preemptive CD20 CAR-T Therapy
A Beijing Gobroad Hospital study used preemptive CD20 CAR-T as consolidation for r/r DLBCL patients in partial remission after CD19 CAR-T, achieving an 84% complete response rate.
Read more →
May 17, 2026
Hospital Guide: Peking University International Hospital (PKUIH)
Peking University International Hospital offers 1,800 beds, 36 medical centers, a ZAP-X radiosurgical robot, and multilingual support tailored to international patients.
Read more →
May 16, 2026
Why Do Top Hospitals Recommend CyberKnife for Prostate Cancer?
Non-invasive CyberKnife for prostate cancer precisely locks onto tumors, shortens treatment to one week (3-5 sessions), and safeguards post-treatment quality of life.
Read more →
May 15, 2026
From the US to China: An Advanced Lung Cancer Patient's Immunotherapy Journey
Turned away by MD Anderson, a man in his seventies with both Parkinson's and advanced lung cancer traveled to Jiahui in Shanghai for immunotherapy drug Evotazumab and stabilized.
Read more →
May 14, 2026
China's First Robot-Assisted Lumbar Revision Surgery at West China Hospital
On Dec 25, 2025, West China Hospital performed China's first robot-assisted OLIF lumbar fusion: 5 cm incision, under 10 ml blood loss, patient walking again within 2 hours.
Read more →
May 13, 2026
From Bench to Bedside: Gene Therapy for Thalassemia in China
China has built a robust research framework for thalassemia gene therapy: BCL11A/HBG stem-cell editing at 80-90% efficiency, freeing many patients from transfusions.
Read more →
May 12, 2026
67-Year-Old with High Tumor Burden SCLC Achieves PFS Over 7 Months
An ES-SCLC case with lung, node, spleen and brain metastases: two MDT discussions led to a four-drug regimen plus stepwise radiotherapy, giving PFS over 7 months.
Read more →
May 11, 2026
Seven-Year Anti-Cancer Journey: From MDS to AML, a Second-Time Mom Finally Sees the Dawn
Awen's story: from MDS to AML, severe rejection and repeated relapses, to a second stem cell transplant at Beijing GoBroad Boren Hospital that brought remission and new life.
Read more →
May 10, 2026
Proton Therapy Snipes Dual Cancer Foci in Prostate and Rectum, Marked Tumor Shrinkage in Man in His Sixties
Seeking proton therapy at Guangzhou Concord Cancer Center, Mr. C was found to have a second primary rectal cancer. After 28 sessions, TPSA dropped and both tumors shrank.
Read more →
May 09, 2026
Chinese Doctors Set New Record: Tumor Disappears in 84-Year-Old Pancreatic Cancer Patient
At the Second Affiliated Hospital of Zhejiang University, 84-year-old Ms. Zhu underwent total pancreatectomy with autologous islet transplantation (TP-IAT). The tumor disappeared.
Read more →